Abstract
Aims and background
Adult granulosa cell tumor has a low malignant potential but requires an extensive follow-up of more than 5 years to accurately assess tumor activity. The aim of the present study was to evaluate the clinical characteristics, the treatment and the outcome of this rare ovarian tumor.
Study design
A retrospective review of 35 cases treated at primary onset of disease during a 23-year period from 1971 to 1993.
Results
The disease-free survival rate for stages IA-B-C at 5 and 10 years was 90% and 84%, respectively; for stages III-IV the 5-year freedom from progression rate was 16%.
Conclusions
The most important prognostic factor appears to be the extent of tumor involvement outside of the ovary.
Get full access to this article
View all access options for this article.
